← Leaderboards
Linda Lea Johnson
Onl Therapeutics, Inc.
$1,408,246
Attributed
$1,408,246
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2014–15$2M$1.5M$1M$500K$0
'14
'15
Funding mix
By agency
NIH$1,408,246 · 1
By mechanism
R44$1,408,246 · 1
Top collaborators
No co-investigators on record.
Most similar at Onl Therapeutics, Inc.
Same institution · by research overlap
- Andrew Joseph Kocab$699,528
- Jana Van De Goor$1,219,466
- Jeffrey A Jamison$421,640
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectAge Related Macular DegenerationAgreementAnatomyAnimalsApoptosisApplications GrantsAutomobile DrivingBackBiotechnologyBlindnessBrainCell DeathCessation Of LifeChronicClinical ResearchClinical Trial Protocol DocumentClinical TrialsCommercial ApplicationCommercializationCostDesignDoseAcute
Grant awards (3)
Preclinical development of ONL-101 for photoreceptor protection in retinal detach$30,875
R44 · FY2015 · EY · contact PI
Preclinical development of ONL-101 for photoreceptor protection in retinal detach$5,000
R44 · FY2015 · EY · contact PI
Preclinical development of ONL-101 for photoreceptor protection in retinal detach$1,372,371
R44 · FY2014 · EY · contact PI